WA
TERN

WPG Advisers’s Terns Pharmaceuticals TERN Stock Holding History

WPG Advisers’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-66
Closed -$3.48K – 1585
2026
Q1 		$3.48K Buy
+66
New +$2.71K ﹤0.01% 964

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WPG Advisers's TERN Position: Q2 2026 in Review

WPG Advisers sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 66 shares — an estimated $3.48K sold.

WPG Advisers first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $3.48K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • WPG Advisers reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • WPG Advisers sold 66 Terns Pharmaceuticals shares in Q2 2026, an estimated $3.48K.
  • WPG Advisers first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • WPG Advisers's Terns Pharmaceuticals position peaked at $3.48K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.